Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000059243) titled 'Prospective cohort study of Paclitaxel plus Carboplatin plus Bevacizumab Therapy as First Line Chemotherapy for Advanced Ovarian Clear cell Carcinoma' on Oct. 1.
Study Type: Observational
Study Design:
Not selected Not selected
Primary Sponsor: Chiba University Hospital
Condition:
Advanced ovarian clear cell carcinoma
Recruitment Status: Not Recruiting
Phase: Not selected
Date of First Enrollment: 2025/10/01
Target Sample Size: 50
Countries of Recruitment:
Japan
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067688
Published by HT Digital Content Servi...